165 related articles for article (PubMed ID: 31483844)
1. B7-1 drives TGF-β stimulated pancreatic carcinoma cell migration and expression of EMT target genes.
Kang JH; Jung MY; Leof EB
PLoS One; 2019; 14(9):e0222083. PubMed ID: 31483844
[TBL] [Abstract][Full Text] [Related]
2. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
3. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
[TBL] [Abstract][Full Text] [Related]
4. Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells.
Liu F; Korc M
Mol Cancer Ther; 2012 Oct; 11(10):2138-48. PubMed ID: 22869556
[TBL] [Abstract][Full Text] [Related]
5. Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling.
Xu M; He J; Li J; Feng W; Zhou H; Wei H; Zhou M; Lu Y; Zeng J; Peng W; Du F; Gong A
Br J Cancer; 2017 Jan; 116(1):91-99. PubMed ID: 27898661
[TBL] [Abstract][Full Text] [Related]
6. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.
Thakur AK; Nigri J; Lac S; Leca J; Bressy C; Berthezene P; Bartholin L; Chan P; Calvo E; Iovanna JL; Vasseur S; Guillaumond F; Tomasini R
Cell Death Differ; 2016 Aug; 23(8):1358-70. PubMed ID: 26943320
[TBL] [Abstract][Full Text] [Related]
7. Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.
Sommerova L; Ondrouskova E; Vojtesek B; Hrstka R
BMC Cancer; 2017 Aug; 17(1):546. PubMed ID: 28810836
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
9. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
[TBL] [Abstract][Full Text] [Related]
10. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.
Jungert K; Buck A; von Wichert G; Adler G; König A; Buchholz M; Gress TM; Ellenrieder V
Cancer Res; 2007 Feb; 67(4):1563-70. PubMed ID: 17308095
[TBL] [Abstract][Full Text] [Related]
11. JianPi JieDu Recipe Inhibits Epithelial-to-Mesenchymal Transition in Colorectal Cancer through TGF-
Liu X; Ji Q; Deng W; Chai N; Feng Y; Zhou L; Sui H; Li C; Sun X; Li Q
Biomed Res Int; 2017; 2017():2613198. PubMed ID: 28299321
[TBL] [Abstract][Full Text] [Related]
12. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.
Guo Y; Cui W; Pei Y; Xu D
Gynecol Oncol; 2019 Jun; 153(3):639-650. PubMed ID: 30928020
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
[TBL] [Abstract][Full Text] [Related]
14. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
[TBL] [Abstract][Full Text] [Related]
15. Human Surfactant Protein D Suppresses Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells by Downregulating TGF-β.
Kaur A; Riaz MS; Singh SK; Kishore U
Front Immunol; 2018; 9():1844. PubMed ID: 30158928
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer.
Funaki S; Shintani Y; Kawamura T; Kanzaki R; Minami M; Okumura M
Oncol Rep; 2017 Oct; 38(4):2277-2284. PubMed ID: 28849209
[TBL] [Abstract][Full Text] [Related]
18. Itraconazole inhibits invasion and migration of pancreatic cancer cells by suppressing TGF-β/SMAD2/3 signaling.
Chen K; Cheng L; Qian W; Jiang Z; Sun L; Zhao Y; Zhou Y; Zhao L; Wang P; Duan W; Ma Q; Yang W
Oncol Rep; 2018 Apr; 39(4):1573-1582. PubMed ID: 29484419
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
